BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11284461)

  • 1. Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Long-term Safety of Depakote in Headache Prophylaxis Study Group.
    Silberstein SD; Collins SD
    Headache; 1999 Oct; 39(9):633-43. PubMed ID: 11284461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study.
    Apostol G; Lewis DW; Laforet GA; Robieson WZ; Fugate JM; Abi-Saab WM; Saltarelli MD
    Headache; 2009 Jan; 49(1):45-53. PubMed ID: 19040679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of divalproex sodium extended-release in the prophylaxis of migraine headaches: results of an open-label extension trial in adolescents.
    Apostol G; Pakalnis A; Laforet GA; Robieson WZ; Olson E; Abi-Saab WM; Saltarelli M
    Headache; 2009 Jan; 49(1):36-44. PubMed ID: 19040678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis.
    Freitag FG; Collins SD; Carlson HA; Goldstein J; Saper J; Silberstein S; Mathew N; Winner PK; Deaton R; Sommerville K;
    Neurology; 2002 Jun; 58(11):1652-9. PubMed ID: 12058094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migraine prophylaxis with divalproex.
    Mathew NT; Saper JR; Silberstein SD; Rankin L; Markley HG; Solomon S; Rapoport AM; Silber CJ; Deaton RL
    Arch Neurol; 1995 Mar; 52(3):281-6. PubMed ID: 7872882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divalproex sodium extended-release for the prophylaxis of migraine headache.
    Freitag FG
    Expert Opin Pharmacother; 2003 Sep; 4(9):1573-8. PubMed ID: 12943487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of divalproex sodium in the prophylactic treatment of children with migraine.
    Caruso JM; Brown WD; Exil G; Gascon GG
    Headache; 2000 Sep; 40(8):672-6. PubMed ID: 10971664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura.
    Kaniecki RG
    Arch Neurol; 1997 Sep; 54(9):1141-5. PubMed ID: 9311358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study.
    Apostol G; Cady RK; Laforet GA; Robieson WZ; Olson E; Abi-Saab WM; Saltarelli M
    Headache; 2008 Jul; 48(7):1012-25. PubMed ID: 18705027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divalproex sodium in migraine prophylaxis: a dose-controlled study.
    Klapper J
    Cephalalgia; 1997 Apr; 17(2):103-8. PubMed ID: 9137847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divalproex in the long-term treatment of chronic daily headache.
    Freitag FG; Diamond S; Diamond ML; Urban GJ
    Headache; 2001 Mar; 41(3):271-8. PubMed ID: 11264687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
    MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S
    Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of divalproex on metabolic parameters is dose related in migraine prophylaxis.
    Green MW; Giordano S; Jiang P; Jafari M; Smith TB
    Headache; 2005 Sep; 45(8):1031-7. PubMed ID: 16109117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Valproic acid in prophylactic treatment of migraine].
    Arnold G; Einhäupl KM
    Nervenarzt; 1998 Oct; 69(10):913-8. PubMed ID: 9834484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine.
    Blumenfeld AM; Schim JD; Chippendale TJ
    Headache; 2008 Feb; 48(2):210-20. PubMed ID: 18047502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis.
    He A; Song D; Zhang L; Li C
    J Headache Pain; 2017 Dec; 18(1):26. PubMed ID: 28220376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric migraine prophylaxis with divalproex.
    Pakalnis A; Greenberg G; Drake ME; Paolichi J
    J Child Neurol; 2001 Oct; 16(10):731-4. PubMed ID: 11669346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective "real-world" study.
    Krymchantowski AV; Jevoux CC
    Headache; 2011 Apr; 51(4):554-8. PubMed ID: 21457240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divalproex sodium in the treatment of migraine and cluster headaches.
    Gallagher RM; Mueller LL; Freitag FG
    J Am Osteopath Assoc; 2002 Feb; 102(2):92-4. PubMed ID: 11866398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.